US awards new US$628 million contract to boost output of potential COVID-19 vaccine
WASHINGTON: The US government on Monday (Jun 1) entered into a US$628 million contract with drugmaker Emergent BioSolutions to boost manufacturing capacity for a potential COVID-19 vaccine.
As drugmakers race to develop vaccines, tests and therapies for COVID-19, the United States is looking to secure manufacturing capacity under its "Operation Warp Speed" program announced in May to accelerate vaccine development.……
America Business Health News International
Leave a comment in Nestia App